Corrigendum to ‘Association of sugammadex, neostigmine, or pyridostigmine for reversal of neuromuscular block with postoperative bradycardia: a multicentre, retrospective observational study’ (Br J Anaesth 2025; 135: 1007–14)

The authors regret an error on page 1008 in the second sentence of the Methods section regarding the institutional review board numbers. The sentence should read as follows:

The study protocol was approved by the institutional review boards of each hospital (approval no. H-2211-010-1373, 2022-11-024-001, and 2023GR0091, respectively), and the requirement for written informed consent was waived owing to the retrospective, anonymous study design.

The authors would like to apologise for any inconvenience caused.

Handling Editor: Hugh C Hemmings Jr